Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Barclays PLC's stake in Zentalis Pharmaceuticals, Inc. fell to 3.17% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Barclays PLC's stake in Zentalis Pharmaceuticals, Inc. fell to 3.17%, 2,263,328 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 3.17%
- Shares
- 2,263,328
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 3.17% | 2,263,328 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Barclays PLC
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G · Barclays PLC · Nov 12, 2025
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Johnson David Michael · Jun 18, 2026